This drug does not appear (although the sample size is limited) to be associated with an increased risk for major malformations above baseline.
No takes yet. Share an insight, caveat, or question.
Einarson et al. (2004) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: